Heart failure (HF) with preserved ejection (HFpEF) constitutes a large and growing
proportion of patients with HF around the world, and is now responsible for more than half of …

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder
developing from multiple aetiologies with overlapping pathophysiological mechanisms …

Aims Biomarker‐driven prognostic models incorporating N‐terminal pro‐B‐type natriuretic
peptide (NT‐proBNP) and high‐sensitivity cardiac troponin T (hs‐cTnT) in heart failure (HF) …

Heart failure (HF) with preserved ejection fraction (HFpEF) is an increasingly frequent form
and is estimated to be the dominant form of HF. On the other hand, HFpEF is a syndrome …

Heart failure with preserved ejection fraction (HFpEF) is increasingly recognised and
diagnosed in clinical practice, a trend driven by an ageing population and a rise in …

Background: Anemia is a commonly occurring comorbidity in patients with heart failure (HF).
Although there are a few reports of a higher prevalence of mortality and hospitalization …

Background: The first admission for acute heart failure with preserved ejection fraction
(HFpEF) drastically influences the short-term prognosis. Baseline characteristics may predict …

Aims Anemia is common in patients with heart failure with preserved ejection fraction
(HFpEF) and is associated with exercise intolerance. However, there are limited data on …

Aims: The aim of this study was to assess the prevalence of anemia and iron deficiency in
patients with heart failure with preserved ejection fraction (HFpEF) and its impact on clinical …

Patients with heart failure with preserved ejection fraction (HFpEF) have a significantly
elevated risk of sudden cardiac death (SCD). However, few imaging data have been …